Last reviewed · How we verify

NCT06978491

Evaluation of the Effect of Postoperative Analgesia Techniques With ObsQoR-10

Recruiting now NA Last updated 28 May 2025
What this trial tests

NA trial testing Group C in Pain, Postoperative in 75 participants. Currently enrolling.

Timeline
16 May 2025
Primary endpoint
1 October 2025
5 October 2025

Quick facts

Lead sponsorEskisehir Osmangazi University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment75
Start date16 May 2025
Primary completion1 October 2025
Estimated completion5 October 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Eskisehir Osmangazi University

Who can join

Adults 18 to 50, female only, with Pain, Postoperative or Postoperative Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this study is to evaluate the effects of postoperative analgesia techniques-transversus abdominis plane (TAP) block and wound infiltration-on recovery in patients undergoing elective cesarean section, using the Obstetric Quality of Recovery-10 (ObsQoR-10) questionnaire. The secondary objective is to assess pain scores, analgesic consumption, and adverse effects such as nausea, vomiting, and pruritus within the first 24 hours postoperatively.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Group C

Trials testing the same drug.

Other recruiting trials for Pain, Postoperative

Currently open trials in the same condition.

Other Eskisehir Osmangazi University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06978491.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing